Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Deciphering the Heterogeneity of Acute Myeloid Leukemia through Chromatin Accessibility Profiling

Blood (2024) 144 (Supplement 1): 639.

https://doi.org/10.1182/blood-2024-200415

Published: 2024

Journal Articles

A Phase I/II Study Investigating Karonudib in Patients with Refractory Haematological Malignancies

Stefan Deneberg, Bertil Uggla, Austin Smith, Theresa Sandvall, Maria Klockare, Olof Breuer, Ulrika Warpman Berglund, Thomas Helleday

Blood (2024) 144 (Supplement 1): 6010.

https://doi.org/10.1182/blood-2024-209387

Published: 2024

Journal Articles

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Blood (2023) 142 (1): 73–89.

https://doi.org/10.1182/blood.2022016896

Published: 2023

Includes: Supplemental data

Journal Articles

AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding

Huthayfa Mujahed, Sophia Miliara, Anne Neddermeyer, Sofia Bengtzén, Christer Nilsson, Stefan Deneberg, Lina Cordeddu, Karl Ekwall, Andreas Lennartsson, Sören Lehmann

Blood (2020) 136 (3): 339–352.

https://doi.org/10.1182/blood.2019002326

Published: 2020

Includes: Supplemental data

Journal Articles

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Gunnar Juliusson, Oskar Hagberg, Vladimir Lj Lazarevic, Emma Ölander, Petar Antunovic, Jörg Cammenga, Lovisa Wennström, Lars Möllgård, Mats Brune, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Åsa Rangert Derolf, Martin Höglund

Blood (2019) 134 (18): 1558–1561.

https://doi.org/10.1182/blood.2019001728

Published: 2019

Includes: Supplemental data

Journal Articles

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Monika Dolinska, Johannis Klang, Pingnan Xiao, MD, Andranik Durgaryan, Lakshmi Sandhow, Anne-Sofie Johansson, Makoto Kondo, Stefan Deneberg, MD, PhD, Johanna Ungerstedt, Associate Professor, Katarina Le Blanc, MD, PhD, Leif Stenke, MD PhD, Marja Ekblom, Ulla Stromberg, MDPhD, Satu Mustjoki, MD PhD, Soren Lehmann, MD PhD, Hong Qian, PhD

Blood (2015) 126 (23): 2398.

https://doi.org/10.1182/blood.V126.23.2398.2398

Published: 2015

Journal Articles

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Stefan Deneberg, MD, PhD, Ebba Lundin, Vladimir Lazarevic, Lina Benson, Bertil Uggla, MDPhD, Petar Antunovic, MD, Lars Mollgard, Sören Lehmann, Prof, Gunnar Juliusson, MD PhD, Martin Höglund, Ass Prof, Asa Rangert Derolf, MDPhD

Blood (2015) 126 (23): 3748.

https://doi.org/10.1182/blood.V126.23.3748.3748

Published: 2015

Journal Articles

Genome-Wide DNA Methylation Analysis Shows Enrichment of Differential Methylation in “Open Seas” and Enhancers and Reveals Hypomethylation in DNMT3A Mutated Cytogenetically Normal AML (CN-AML)

Ying Qu, MD, M.Sc, Andreas Lennartsson, PhD, Verena I. Gaidzik, MD, Ph.D, Stefan Deneberg, MD, Ph.D, Sofia Bengtzén, Mohsen Karimi Arzenani, PhD, Lars Bullinger, MD, PhD, Konstanze Döhner, MD, Ph.D, Sören Lehmann, MD, PhD

Blood (2012) 120 (21): 653.

https://doi.org/10.1182/blood.V120.21.653.653

Published: 2012

Journal Articles

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

Stefan Deneberg, Philippe Guardiola, Andreas Lennartsson, Ying Qu, Verena Gaidzik, Odile Blanchet, Mohsen Karimi, Sofia Bengtzén, Hareth Nahi, Bertil Uggla, Ulf Tidefelt, Martin Höglund, Christer Paul, Karl Ekwall, Konstanze Döhner, Sören Lehmann

Blood (2011) 118 (20): 5573–5582.

https://doi.org/10.1182/blood-2011-01-332353

Published: 2011

Includes: Supplemental data

Journal Articles

Global and HOX Gene DNA Methylation In Normal Karyotype Acute Myeloid Leukemia: Clinical Implications and Molecular Correlations

Stefan Deneberg, MD, Andreas Lennartsson, PhD, Bertil Uggla, MD, PhD, Verena Gaidzik, Andrea Corbacioglu, PhD, Hareth Nahi, MD, PhD, Konstanze Dohner, MD, PhD, Karl Ekwall, MD, PhD, Ulf Tidefelt, MD, PhD, Martin Hoglund, MD, PhD, Sören Lehmann, MD, PhD

Blood (2010) 116 (21): 231.

https://doi.org/10.1182/blood.V116.21.231.231

Published: 2010

Journal Articles

In Vitro and Ex Vivo Studies On Cell Lines and Primary Human Leukemia Cells of the Effects of APR-246 Alone and in Combination with Conventional Chemotherapeutic Drugs.

Kerstin Jonsson-Videsater, Dina Ali, MD, Hareth Nahi, Sofia Bengtzen, Stefan Deneberg, Christer Paul, Professor, Soren Lehmann, MD, PhD

Blood (2009) 114 (22): 2751.

https://doi.org/10.1182/blood.V114.22.2751.2751

Published: 2009

Journal Articles

Different Incidence and Implications of DNA Hypermethylation in De Novo AML Compared to High-Risk MDS and AML Following MDS.

Stefan Deneberg, Michael Grövdal, Monika Jansson, Verena I. Gaidzik, Andrea Corbacioglu, Hareth Nahi, MD, PhD, Sofia Bengtzen, Konstanze Döhner, Christer Paul, Eva Hellström-Lindberg, Sören Lehmann, MD, PhD

Blood (2008) 112 (11): 3337.

https://doi.org/10.1182/blood.V112.11.3337.3337

Published: 2008

Journal Articles

Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival.

Esbjorn O. Paul, MD, Stefan Deneberg, MD, Soren Lehmann, MD, PhD, Sofia Bengtzén, Ms., Hareth Nahi, MD, PhD.

Blood (2007) 110 (11): 4261.

https://doi.org/10.1182/blood.V110.11.4261.4261

Published: 2007

NARROW

Deciphering the Heterogeneity of Acute Myeloid Leukemia through Chromatin Accessibility Profiling

A Phase I/II Study Investigating Karonudib in Patients with Refractory Haematological Malignancies

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Genome-Wide DNA Methylation Analysis Shows Enrichment of Differential Methylation in “Open Seas” and Enhancers and Reveals Hypomethylation in DNMT3A Mutated Cytogenetically Normal AML (CN-AML)

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

Global and HOX Gene DNA Methylation In Normal Karyotype Acute Myeloid Leukemia: Clinical Implications and Molecular Correlations

In Vitro and Ex Vivo Studies On Cell Lines and Primary Human Leukemia Cells of the Effects of APR-246 Alone and in Combination with Conventional Chemotherapeutic Drugs.

Different Incidence and Implications of DNA Hypermethylation in De Novo AML Compared to High-Risk MDS and AML Following MDS.

Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only